Abstract:Data-independent acquisition (DIA) has recently emerged as a powerful quantitative approach for large-scale proteome quantification, providing a sensitive and reproducible alternative to data-dependent acquisition (DDA). However, lack of compatible multiplexed quantification methods is a bottleneck of DIA. To alleviate this challenge, we present a mass defect based four-plex data-independent acquisition strategy, termed "MdFDIA", for parallel analysis of four different protein samples in a DIA experiment without the additional complexity of tandem mass spectrometry (MS2) spectra. MdFDIA is a hybrid approach that combines stable isotope labeling with amino acids in cell culture (SILAC) and dimethyl labeling. Briefly, the isotopes (13)C6(15)N(2)-lysine (+8.0142 Da, light) and D8-lysine (+8.0512 Da, heavy) were metabolically embedded in different proteome samples during cell culture. Then, two (13)C6(15)N(2)-lysine and D8-lysine labeled protein samples were digested with Lys-C, followed by in vitro labeling with light (2(13)CD(2)H, +34.06312 Da) and heavy (2CD(3), +34.06896 Da) dimethyl groups, respectively, producing four different pseudoisobaric labeled protein samples. The labeled samples were then equally mixed and analyzed by DIA. The subtle mass differences between the four labeled forms in MS2 scans can be resolved on an Orbitrap Fusion Lumos instrument to facilitate quantification without abundance information encoded in MS2 spectra. Additionally, a systematic investigation was carried out and revealed that MdFDIA enabled a significant decrease of the adverse impact on the accuracy of the quantitative assays arising from the chromatographic isotope effect, especially the deuterium effect, which typically occurs in a DDA experiment. Additionally, MdFDIA provided a method for validating the fragment type in the DIA spectra identification result. Furthermore, MdFDIA was applied to quantitative proteome analyses of four different breast cancer cell lines, demonstrating the feasibility of this strategy for biological applications.

Benchmarking DIA data analysis workflows

Benefit of In Silico Predicted Spectral Libraries in Data-Independent Acquisition Data Analysis Workflows

Benchmarking of analysis strategies for data-independent acquisition proteomics using a large-scale dataset comprising inter-patient heterogeneity

Interrogating data-independent acquisition LC-MS/MS for affinity proteomics

Evaluation of DDA Library-Free Strategies for Phosphoproteomics and Ubiquitinomics Data-Independent Acquisition Data.

A New Evaluation Metric for Quantitative Accuracy of LC-MS/MS-Based Proteomics with Data-Independent Acquisition

DIAmeter: matching peptides to data-independent acquisition mass spectrometry data

Comparison of TIMS-PASEF quantitative proteomics data-analysis workflows using FragPipe, DIA-NN, and Spectronaut from a user’s perspective

A Comparative Analysis of Data Analysis Tools for Data-Independent Acquisition Mass Spectrometry

Discovering Protein Biomarkers from Clinical Peripheral Blood Mononuclear Cells Using Data-Independent Acquisition Mass Spectrometry.

Combining data independent acquisition with spike-in SILAC (DIA-SiS) improves proteome coverage and quantification

Data Independent Acquisition to Inform the Development of Targeted Proteomics Assays Using a Triple Quadrupole Mass Spectrometer

Comparative Evaluation of Data Dependent and Data Independent Acquisition Workflows Implemented on an Orbitrap Fusion for Untargeted Metabolomics

Mdfdia: A Mass Defect Based Four-Plex Data-Independent Acquisition Strategy For Proteome Quantification

[Data-driven mass spectrometry methods (DDA) and data-independent methods (DIA) used in the analysis of biological material]

In silico spectral libraries by deep learning facilitate data-independent acquisition proteomics

DIA-Umpire: comprehensive computational framework for data-independent acquisition proteomics

AlphaDIA enables End-to-End Transfer Learning for Feature-Free Proteomics

Prioritize biologically relevant ions for data-independent acquisition (BRI-DIA) in LC-MS/MS-based lipidomics analysis

MetaboMSDIA: A tool for implementing data-independent acquisition in metabolomic-based mass spectrometry analysis

Data-independent acquisition: A milestone and prospect in clinical mass spectrometry-based proteomics